ArticleDrug design, development and therapy2019

siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo.

Fang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.